LeMaitre Vascular Inc. (LMAT)
86.28
1.61 (1.90%)
At close: Apr 17, 2025, 3:59 PM
86.36
0.09%
After-hours: Apr 17, 2025, 04:38 PM EDT
LeMaitre Vascular Revenue Breakdown
| Period Ending | Jun 30, 2012 |
|---|---|
| Endovascular and Other Revenue | 2.51M |
| Endovascular and Other Revenue Growth | n/a |
| Open Vascular Revenue | 11.85M |
| Open Vascular Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|
| Americas Revenue | 130.31M | 109.44M | 102.27M | 81.47M | 69.36M | 63.65M |
| Americas Revenue Growth | +19.07% | +7.02% | +25.52% | +17.46% | +8.97% | n/a |
| Asia Pacific Revenue | 12.08M | 10.36M | 10.03M | 8.7M | 8.39M | 6.6M |
| Asia Pacific Revenue Growth | +16.60% | +3.30% | +15.21% | +3.69% | +27.17% | n/a |
| Emea Revenue | 51.1M | 41.85M | 42.13M | 39.19M | 39.48M | 35.32M |
| Emea Revenue Growth | +22.09% | -0.66% | +7.50% | -0.73% | +11.78% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.37M | 18.33M | 20.7M | 17.27M | 17.41M | 17.94M | 18.83M | 15.53M | 15.46M | 15.57M | 15.1M | 14.2M | 12.95M | 13M | 13.01M | 11.99M | 11.06M | 10.02M | 13.14M | 12.48M | 11.98M | 12.14M | 12.79M | 11.28M | 10.61M | 11.34M | 11.79M | 10.35M | 10.76M | 10.35M | 11.5M | 10.76M | 10.14M | 9.95M | 9.61M | 9.55M | 8.94M | 8.82M | 9.47M |
| Selling, General, and Administrative Revenue Growth | +11.14% | -11.44% | +19.84% | -0.80% | -2.94% | -4.73% | +21.22% | +0.49% | -0.74% | +3.12% | +6.37% | +9.68% | -0.45% | -0.05% | +8.53% | +8.41% | +10.38% | -23.74% | +5.25% | +4.18% | -1.35% | -5.04% | +13.42% | +6.33% | -6.47% | -3.80% | +13.92% | -3.87% | +4.03% | -10.05% | +6.86% | +6.20% | +1.87% | +3.54% | +0.64% | +6.76% | +1.38% | -6.89% | n/a |
| Research and Development Revenue | 3.66M | 4.28M | 4.09M | 4.35M | 4.22M | 4.52M | 3.88M | 3.55M | 3.46M | 3.35M | 2.93M | 3.46M | 2.85M | 2.65M | 2.84M | 2.87M | 2.1M | 2.14M | 2.99M | 2.5M | 2.28M | 2.26M | 2.24M | 2.35M | 2.04M | 1.99M | 1.82M | 1.58M | 1.76M | 1.63M | 1.66M | 1.52M | 1.54M | 1.63M | 1.45M | 1.57M | 1.42M | 1.33M | 1.15M |
| Research and Development Revenue Growth | -14.66% | +4.69% | -5.95% | +3.01% | -6.47% | +16.54% | +9.03% | +2.66% | +3.47% | +14.12% | -15.19% | +21.38% | +7.39% | -6.75% | -0.87% | +36.75% | -1.92% | -28.56% | +19.81% | +9.56% | +1.11% | +0.71% | -4.56% | +15.22% | +2.46% | +8.93% | +15.29% | -10.11% | +7.77% | -1.45% | +9.01% | -1.17% | -5.81% | +13.00% | -8.19% | +10.84% | +6.76% | +15.54% | n/a |
| Sales and Marketing Revenue | 11.44M | 10.98M | 11.69M | 10.27M | 9.67M | 10.22M | 10.9M | 8.6M | 8.23M | 8.24M | 7.85M | 7.45M | 6.94M | 6.8M | 6.47M | 5.91M | 5.16M | 4.69M | 7.95M | 7.45M | 7.43M | 7.61M | 7.84M | 6.81M | 6.62M | 6.79M | 7.09M | 6.19M | 6.2M | 6.6M | 6.95M | 6.75M | 6.54M | 6.54M | 6.27M | 5.91M | 5.49M | 5.52M | 5.86M |
| Sales and Marketing Revenue Growth | +4.16% | -6.01% | +13.81% | +6.15% | -5.32% | -6.25% | +26.71% | +4.51% | -0.16% | +4.99% | +5.44% | +7.26% | +2.03% | +5.21% | +9.37% | +14.64% | +10.05% | -41.02% | +6.62% | +0.31% | -2.42% | -2.96% | +15.13% | +2.90% | -2.50% | -4.20% | +14.47% | -0.11% | -6.03% | -5.10% | +2.98% | +3.24% | +0.03% | +4.24% | +6.07% | +7.74% | -0.54% | -5.79% | n/a |